Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)

NCT02588677 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

394

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: Masitinib (4.5)
DRUG: Riluzole
DRUG: Placebo
DRUG: Masitinib (3.0)

Sponsor

AB Science